Fundraising Fox
Zevra
1 known investors
Find your way into Zevra
Sign up to see every warm intro you have to Zevra
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Zevra team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Zevra Therapeutics develops and commercializes rare disease treatments, including therapies for Niemann-Pick disease type C and urea cycle disorders. The company serves patients with inherited metabolic and genetic disorders through FDA-approved pharmaceutical products.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Zevra do?
- Zevra Therapeutics develops and commercializes rare disease treatments, including therapies for Niemann-Pick disease type C and urea cycle disorders. The company serves patients with inherited metabolic and genetic disorders through FDA-approved pharmaceutical products.
- Who are Zevra's investors?
- Zevra's investors include HEALTHCARE ROYALTY PARTNERS.